German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany.
Heidelberg University Hospital, Diagnostic and Interventional Radiology, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
Nutrients. 2019 Mar 4;11(3):544. doi: 10.3390/nu11030544.
Preliminary evidence suggests that weight loss among obese has differential metabolic effects depending on the presence of non-alcoholic fatty liver disease (NAFLD). We assessed whether NAFLD predisposes to differential changes in liver fat content, liver function, and metabolic parameters upon diet-induced weight loss in a 50-week intervention trial.
143 overweight and obese non-smokers underwent a 12-week dietary intervention and a 38-week follow-up. Diet-induced changes in anthropometric measures, circulating biomarkers, and magnetic resonance (MR)-derived liver fat content and adipose tissue volumes were evaluated by mixed linear models stratifying by NAFLD at baseline.
The prevalence of NAFLD at baseline was 52%. Diet-induced weight loss after 12 (NAFLD: 4.8 ± 0.5%, No NAFLD: 5.1 ± 0.5%) and 50 weeks (NAFLD: 3.5 ± 0.7%, No NAFLD: 3.5 ± 0.9%) was similar in both groups, while the decrease in liver fat was significantly greater in the NAFLD group (week 12: 32.9 ± 9.5% vs. 6.3 ± 4.0%; week 50: 23.3 ± 4.4% vs. 5.0 ± 4.2%). Decreases in biomarkers of liver dysfunction (GGT, ALT, AST) and HOMA IR were also significantly greater in the NAFLD group. Other metabolic parameters showed no significant differences.
Our data suggest that individuals with NAFLD show greater improvements of liver function and insulin sensitivity after moderate diet-induced weight loss than individuals without NAFLD.
初步证据表明,肥胖者的体重减轻会因非酒精性脂肪性肝病(NAFLD)的存在而产生不同的代谢影响。我们评估了在 50 周干预试验中,NAFLD 是否会导致饮食诱导的体重减轻后肝脂肪含量、肝功能和代谢参数的差异变化。
143 名超重和肥胖的不吸烟者接受了 12 周的饮食干预和 38 周的随访。通过混合线性模型,根据基线时的 NAFLD 对人体测量指标、循环生物标志物以及磁共振(MR)衍生的肝脂肪含量和脂肪组织体积的变化进行分层评估。
基线时 NAFLD 的患病率为 52%。12 周(NAFLD:4.8±0.5%,无 NAFLD:5.1±0.5%)和 50 周(NAFLD:3.5±0.7%,无 NAFLD:3.5±0.9%)后饮食诱导的体重减轻在两组中相似,而 NAFLD 组的肝脂肪减少量显著更大(第 12 周:32.9±9.5%比 6.3±4.0%;第 50 周:23.3±4.4%比 5.0±4.2%)。肝功能障碍的生物标志物(GGT、ALT、AST)和 HOMA IR 的降低在 NAFLD 组也更为显著。其他代谢参数无显著差异。
我们的数据表明,与无 NAFLD 者相比,NAFLD 个体在适度饮食诱导的体重减轻后,肝功能和胰岛素敏感性的改善更为显著。